NVIDA significantly beat expected earnings and revenues. For the quarter, actual earnings were 1.33 against expected .95. Revenue was 2.64B vs 2.37B expected.
While I don't put any weight on "expected" earnings, the difference between actual and expected can be a clue to future market action. It just depends on how much "anticipation" has been built into the current stock price. It is like a large tectonic fault line! It can shift quickly up.... or down.
One item in this report was disconcerting, NVIDA is planning to use buybacks in conjunction with dividends 2017 and 2018 to give 1.25B each year to shareholders. I would prefer all dividends. Companies are almost always wasting shareholders money to buy expensive stock. Dumb move!
NVIDA is high and might go higher, but I would always prefer "A bird in the hand is worth more than two in the bush" (meaning dividend)!
